Clorox Changes Strategy on Vitamins Business: 3 Things Investors Need to Know
(NYSE: CLX) is a highly respected consumer staples company with a stable of iconic brands. It is always looking for new and innovative ways to expand its portfolio, which often includes buying other companies. Although this has worked out well for Clorox (Burt's Bees, for example), it doesn't always pan out as expected. The vitamins business looks like it might be a misstep. Here are three things investors need to know.
Clorox built up its vitamin business through a series of acquisitions. The idea was basically to cobble together a collection of brands to create a more formidable single player. It wasn't a bad plan, considering that consumer health has been a fairly attractive segment of the consumer staples space.
Image source: Getty Images.
Source Fool.com
Clorox Co. Stock
Our community is currently low on Clorox Co. with 3 Buy predictions and 10 Sell predictions.
However, we have a potential of 3.54% for Clorox Co. as the target price of 123 € is above the current price of 118.8 €.
